Ikhabe Elimunyu

-Delile

• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

I-Bitter melon yimifino esetshenziswa eNdiya nakwamanye amazwe ase-Asia. Izithelo nembewu kusetshenziselwa ukwenza umuthi.

Abantu basebenzisa ikhabe elibabayo lesifo sikashukela, ukukhuluphala ngokweqile, izinkinga zesisu namathumbu, nezinye izimo eziningi, kepha abukho ubufakazi obuhle besayensi bokusekela lokhu kusetshenziswa.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze IMELONI ENCANE zimi kanje:

Ubufakazi obanele bokukala ukusebenza kwe ...

• Ukusebenza kwezemidlalo. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-melon extract kunganciphisa ukukhathala kubantu ababamba iqhaza ekuqeqesheni umzimba okuqinile emazingeni aphezulu okushisa.
• Isifo sikashukela. Ucwaningo luyaphikisana futhi aluhambisani. Olunye ucwaningo lukhombisa ukuthi ukuthatha i-melon ebabayo kunganciphisa amazinga kashukela wegazi kwehle ne-HbA1c (isilinganiso sokulawulwa kukashukela wegazi ngokuhamba kwesikhathi) kubantu abane-type 2 yesifo sikashukela. Kepha lezi zifundo zinamaphutha athile. Futhi akukhona konke ukucwaninga okuvumayo. Izifundo ezisezingeni eliphakeme ziyadingeka.
• Isifo sikashukela. Ucwaningo lwakuqala lukhombisa ukuthi ibhece elibabayo alinciphisi ushukela wegazi kubantu abane-prediabetes.
• I-osteoarthritis. Ucwaningo lwakuqala lukhombisa ukuthi ibhece elibabayo lehlisa inani lomuthi wezinhlungu odingwa ngabantu abane-osteoarthritis. Kodwa akubonakali kuthuthukisa izimpawu.
• Ukuqoqwa kwezimpawu ezandisa ubungozi besifo sikashukela, isifo senhliziyo, nesifo sohlangothi (isifo se-metabolic syndrome).
• Uhlobo lwesifo samathumbu esivuthayo (ulcerative colitis).
• I-HIV / AIDS.
• Ukuqunjelwa (i-dyspepsia).
• Ukutheleleka kwamathumbu ngama-parasites.
• Amatshe ezinso.
• Isifo sesibindi.
• Isikhumba, isikhumba esilumayo (psoriasis).
• Izilonda zesisu.
• Ukuphulukiswa kwesilonda.
• Ezinye izimo.

Kudingeka ubufakazi obuningi ukukala ukusebenza kwekhabe elibabayo kulokhu kusetshenziswa.

I-Bitter melon iqukethe ikhemikhali esebenza njenge-insulin ukusiza ukunciphisa amazinga kashukela egazini.

Lapho ithathwa ngomlomo: Ikhabe elibabayo OKUNGENZEKA UKUPHEPHA kubantu abaningi lapho bethathwa ngomlomo isikhathi esifushane (kufika ezinyangeni ezi-4). Umunyu omuncu ungadala isisu esidangele kwabanye abantu. Ukuphepha kokusetshenziswa kwesikhathi eside kwekhabe elibabayo akwaziwa.

Lapho isetshenziswa esikhunjeni: Alukho ulwazi olwanele oluthembekile lokwazi ukuthi ngabe ikhabe elibabayo liphephile yini uma lifakwa esikhunjeni. Kungadala ukuqubuka.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Ikhabe elibabayo MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngomlomo ngesikhathi sokukhulelwa. Amakhemikhali athile kumakhabe ababayo angaqala ukuphuma esikhathini futhi abangele ukukhipha isisu ezilwaneni. Akwanele okwaziwayo ngokuphepha kokusebenzisa ibhece elibabayo ngesikhathi sokuncelisa ibele. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Isifo sikashukela: Umuncu omuncu wehlisa amazinga kashukela egazini. Uma unesifo sikashukela futhi uthatha imishanguzo yokwehlisa ushukela wegazi, ukungeza ibhece elibabayo kungenza ushukela wegazi lakho wehle kakhulu. Bheka ishukela lakho egazini ngokucophelela.

Ukushoda kweGlucose-6-phosphate dehydrogenase (G6PD): Abantu abanokushoda kwe-G6PD bangahle bathuthukise i- "favism" ngemuva kokudla imbewu ebabayo yamakhabe. I-Favism yisimo esiqanjwe ngobhontshisi we-fava, okucatshangwa ukuthi ubanga "igazi elikhathele" (i-anemia), ikhanda, umkhuhlane, ubuhlungu besisu, kanye ne-coma kubantu abathile. Ikhemikhali etholakala ezimbewini ezibabayo zamakhabe ihlobene namakhemikhali kubhontshisi wefava. Uma unokuntuleka kwe-G6PD, gwema ikhabe elibabayo.

Ukuhlinzwa: Kukhona ukukhathazeka ngokuthi i-melon ebabayo ingaphazamisa ukulawulwa kukashukela egazini ngesikhathi nangemva kokuhlinzwa. Yeka ukusebenzisa ibhece elibabayo okungenani amasonto ama-2 ngaphambi kokuhlinzwa okuhleliwe.

Maphakathi

Qaphela ngale nhlanganisela.

Imithi yesifo sikashukela (Imithi elwa nesifo sikashukela)

Umunyu omuncu unganciphisa amazinga kashukela egazini. Imithi yesifo sikashukela nayo isetshenziselwa ukwehlisa ushukela egazini. Ukuthatha ikhabe elibabayo kanye nemithi yesifo sikashukela kungadala ukuthi ushukela wegazi lakho ube phansi kakhulu. Bheka ushukela wegazi lakho eduze. Umthamo wemithi yakho yesifo sikashukela ungadinga ukuguqulwa.

Eminye imishanguzo yesifo sikashukela ifaka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-repaglinide (i-Prandin), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), neminye.

Imithi ethunyelwa ngamaphampu kumaseli (ama-P-Glycoprotein Substrates)

Eminye imithi ihanjiswa ngamaphampu kumaseli. Isithako kumakhabe ababayo singenza la mapampu angasebenzi kahle futhi andise ukuthi eminye imithi ihlala isikhathi esingakanani emzimbeni. Lokhu kungakhuphula ukusebenza noma imiphumela emibi yemithi ethile.
Eminye imithi ehanjiswa amaphampu kumaseli ifaka i-rivaroxaban powder (i-Xarelto), i-apixaban (i-Eliquis), i-linagliptin (i-Tradjenta), i-etoposide (i-Toposar), i-paclitaxel (i-Taxol), i-vinblastine (i-Velban), i-vincristine (i-Vincasar), i-itraconazole (i-Sporanox) amprenavir (Agenerase), indinavir (Crixivan), nelfinavir (Viracept), saquinavir (Invirase), cimetidine (Tagamet), ranitidine (Zantac), diltiazem (Cardizem), verapamil (Calan), corticosteroids, erythromenine (Erythromadine) (Allegra), cyclosporine (Sandimmune), loperamide (Imodium), quinidine (Quinidex), nabanye.

Amakhambi nezithasiselo ezingehlisa ushukela egazini

Umunyu omuncu unganciphisa amazinga kashukela egazini. Ukuyisebenzisa namanye amakhambi noma izithasiselo ezinomphumela ofanayo kungadala ukuthi amazinga kashukela egazi ehle kakhulu. Amanye amakhambi nezengezo ezinganciphisa ushukela wegazi zifaka i-alpha-lipoic acid, i-chromium, i-devil's claw, i-fenugreek, i-garlic, i-guar gum, i-chestnut yamahhashi, i-Panax ginseng, i-psyllium, i-ginseng yaseSiberia, nezinye.

Akukho ukuxhumana okwaziwayo nokudla.

Umthamo ofanele wekhabe elibabayo uncike ezicini eziningana ezifana nobudala bomsebenzisi, impilo, kanye nezinye izimo eziningana. Ngalesi sikhathi, alukho ulwazi olwanele lwesayensi lokunquma uhla olufanele lwamanani wekhabe elibabayo. Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa.

Ikhukhamba lase-Afrika, i-Ampalaya, i-Balsam Pear, i-Balsam-Apple, i-Balsambirne, i-Balsamine, i-Balsamo, i-Bitter Apple, i-Bitter Cucumber, i-Bitter Gourd, i-Bittergurke, i-Carilla Fruit, i-Carilla Gourd, iCerasee, i-Chinli-Chih, i-Concombre Africain, i-Courge Amère, i-Cundeamor, i-Funde Mormordicae Grosvenori, Karavella, Karela, Kareli, Kathilla, Kerala, Korolla, Kugua, Kuguazi, K'u-Kua, Lai Margose, Margose, Melón Amargo, Melon Amer, Momordica, Momordica charantia, Momordica murcata, Momordique, Paroka, Pepino Montero , Poire Balsamique, Pomme de Merveille, P'u-T'ao, Sorosi, Sushavi, Ucche, Insangu Yemifino, Ikhukhamba Lasendle.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. I-Kwak JJ, i-Yook JS, i-Ha MS. Ama-biomarkers angaba khona we-peripheral kanye nokukhathala okuphakathi kubasubathi abaqeqeshiwe abasezingeni eliphakeme lokushisa okuphezulu: isifundo somshayeli noMomordica charantia (ibhece elibabayo). J Immunol Res. 2020; 2020: 4768390. Buka okungaqondakali.
2. ICortez-Navarrete M, Martínez-Abundis E, Pérez-Rubio KG, González-Ortiz M, Méndez-Del Villar M. Momordica charantia management ithuthukisa ukugcinwa kwe-insulin kuhlobo 2 sikashukela mellitus. J Med Ukudla. 2018; 21: 672-7. i-doi: 10.1089 / jmf.2017.0114. Buka okungaqondakali.
3. UPeter EL, uKasali FM, uDeyno S, et al. I-Momordica charantia L. yehlisa i-glycaemia ephakeme ezigulini zesifo sikashukela sohlobo lwe-2: Ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta. J Ethnopharmacol. 2019; 231: 311-24. i-doi: 10.1016 / j.jep.2018.10.033. Buka okungaqondakali.
4. USoo May L, uSanip Z, u-Ahmed Shokri A, u-Abdul Kadir A, uMd Lazin MR. Imiphumela ye-Momordica charantia (i-melon ebabayo) yokwengeza ezigulini ezine-osteoarthritis eyinhloko yamadolo: Isivivinyo esilawulwa ngamehlo esisodwa, esilawulwa ngokungahleliwe. Qedelela iTher Clin Pract. 2018; 32: 181-6. i-doi: 10.1016 / j.ctcp.2018.06.012. Buka okungaqondakali.
5. U-Yue J, uSun Y, u-Xu J, et al. I-Cucurbitane triterpenoids evela esithelweni se-Momordica charantia L. kanye nemisebenzi yabo yokulwa ne-hepatic fibrosis nemisebenzi yokulwa ne-hepatoma. I-Phytochemistry. 2019; 157: 21-7. i-doi: 10.1016 / j.phytochem.2018.10.009. Buka okungaqondakali.
6. UWen JJ, uGao H, uHu JL, et al. Ama-polysaccharides avela ku-Momordica charantia abilile athuthukisa ukukhuluphala kwamagundane akhuluphele kakhulu anamafutha. Umsebenzi Wokudla. 2019; 10: 448-57. i-doi: 10.1039 / c8fo01609g. Buka okungaqondakali.
7. UKonishi T, uSatsu H, uHatsugai Y, et al. Umphumela wokuvimbela ukukhishwa kwekhabe elibabayo emsebenzini we-P-glycoprotein kumaseli we-Caco-2 wamathumbu. UBr J Pharmacol. 2004; 143: 379-87. Buka okungaqondakali.
8. UBoone CH, uStout JR, uGordon JA, et al. Imiphumela emibi yesiphuzo equkethe i-melon extract (CARELA) ku-postprandial glycemia phakathi kwabantu abadala be-prediabetic. Isifo Sikashukela Somsoco. 2017; 7: e241. Buka okungaqondakali.
9. U-Alam MA, Uddin R, Subhan N, uRahman MM, uJain P, uReza HM. Indima ezuzisayo yokwengezwa komunyu obabayo ekukhuluphaleni nasezinkingeni ezihlobene nesifo se-metabolic syndrome. J Lipids. 2015; 2015: 496169. Buka okungaqondakali.
10. I-Somasagara RR, i-Deep G, i-Shrotriya S, i-Patel M, i-Agarwal C, i-Agarwal R. Bitter ijusi lekhabe likhomba izindlela zamangqamuzana ezibangela ukumelana ne-gemcitabine kumaseli womdlavuza we-pancreatic. Int J Oncol. 2015; 46: 1849-57. Buka okungaqondakali.
11. URahman IU, uKhan RU, uRahman KU, uBashir M. Lower hypoglycemic kepha imiphumela ephezulu ye-antiatherogenic yamakhabe ababayo kune-glibenclamide ezigulini zesifo sikashukela sohlobo 2. Umsoco J. 2015; 14: 13. Buka okungaqondakali.
12. UBhattacharya S, Muhammad N, Steele R, Peng G, uRay RB. Indima yokuzivikela komzimba wekhabe elibabayo elikhishwe ekuvimbeleni ukukhula kwekhanda nentamo squamous cell carcinoma. I-Oncotarget. 2016; 7: 33202-9. Buka okungaqondakali.
13. I-Yin RV, uLee NC, uHirpara H, uPhung OJ. T. Umphumela wekhabe elibabayo (Mormordica charantia) ezigulini ezinesifo sikashukela: s ukubuyekeza okuhlelekile nokuhlaziywa kwemeta. Isifo Sikashukela Somsoco. 2014; 4: e145. Buka okungaqondakali.
14. I-Dutta PK, i-Chakravarty AK, i-CHowdhury US, ne-Pakrashi SC. I-Vicine, ubuthi obukhuthaza i-favism obuvela eMomordica charantia Linn. imbewu. I-Indian J Chem 1981; 20B (Agasti): 669-671.
15. I-Srivastava Y. Izici ze-Antidiabetic kanye ne-adaptogenic ye-Momordica charantia ekhishwe: Ukuhlolwa kokuhlola nokwelashwa. I-Phytother Res 1993; 7: 285-289.
16. I-Raman A ne-Lau C. Izakhiwo zokulwa nesifo sikashukela kanye ne-phytochemistry ye-Momordica charantia L. (Cucurbitaceae). I-Phytomedicine 1996; 2: 349-362.
17. UStepka W, uWilson KE, noMadge GE. Uphenyo lokuvimbela inzalo eMomordica. ULloydia 1974; 37: 645.
18. IBaldwa VS, iBhandara CM, iPangaria A, kanye no-al. Ukuhlolwa kwemitholampilo ezigulini ezinesifo sikashukela se-insulin efana ne-insulin etholakala emthonjeni wesitshalo. Upsala J Med Sci 1977; 82: 39-41.
19. UTakemoto, D. J., Dunford, C., noMcMurray, M. M. Imiphumela ye-cytotoxic kanye ne-cytostatic yemelon ebabayo (Momordica charantia) kuma-lymphocyte abantu. Ubuthi 1982; 20: 593-599. Buka okungaqondakali.
20. UDixit, V. P., Khanna, P., noBhargava, S. K. Imiphumela ye-Momordica charantia L. izithelo ezikhishwe emsebenzini wamasende wenja. UPlanta Med 1978; 34: 280-286. Buka okungaqondakali.
21. I-Aguwa, C.N neMittal, G. C. Imiphumela ye-Abortifacient yezimpande zeMomordica angustisepala. J Ethnopharmacol. 1983; 7: 169-173. Buka okungaqondakali.
22. I-Akhtar, M. S. Isivivinyo se-Momordica charantia Linn (Karela) powder ezigulini ezinesifo sikashukela esivuthiwe. J Pak. UMed Assoc 1982; 32: 106-107. Buka okungaqondakali.
23. Welihinda, J., Arvidson, G., Gylfe, E., Hellman, B., noKarlsson, E. Umsebenzi odedela i-insulin wesitshalo esishisayo i-momordica charantia. I-Acta Biol Med Ger 1982; 41: 1229-1240. Buka okungaqondakali.
24. UChan, W. Y., Tam, P. P., noYeung, H. W. Ukuqedwa kokukhulelwa kwasekuqaleni egundeni nge-beta-momorcharin. Ukuvimbela inzalo ngo-1984; 29: 91-100. Buka okungaqondakali.
25. UTakemoto, D. J., Jilka, C., noKresie, R. Ukuhlanzwa nokuchazwa kwesici se-cytostatic esivela kumuncu obabayo uMomordica charantia. Lungiselela I-Biochem 1982; 12: 355-375. Buka okungaqondakali.
26. UWong, C. M., Yeung, H. W., noNg, T. B. Ukuhlolwa kweTrichosanthes kirilowii, Momordica charantia kanye neCucurbita maxima (umndeni waseCucurbitaceae) wokuhlanganiswa nomsebenzi we-antilipolytic. J Ethnopharmacol. 1985; 13: 313-321. Buka okungaqondakali.
27. Ng, T. B., Wong, C. M., Li, W. W., noYeung, H. W. Ukuhlukaniswa nokuhlukaniswa kwe-lectin ebopha i-galactose ngemisebenzi ye-insulinomimetic. Kusuka embewini yomuthi omunyu uMomordica charantia (Umndeni Cucurbitaceae). Amaprotheni we-Int J Peptide Res 1986; 28: 163-172. Buka okungaqondakali.
28. Ng, T. B., Wong, C. M., Li, W. W., noYeung, H. W. Ama-molecule afana ne-Insulin eMomordica charantia seed. J Ethnopharmacol. 1986; 15: 107-117. Buka okungaqondakali.
29. Liu, H. L., Wan, X., Huang, X. F., noKong, L.Y. Biotransformation ye-sinapic acid ekhutshwe yi-Momordica charantia peroxidase. J Agric Ukudla Chem 2-7-2007; 55: 1003-1008. Buka okungaqondakali.
30. U-Yasui, Y., Hosokawa, M., Kohno, H., Tanaka, T., noMiyashita, K. imigqa yeseli. I-Chemotherapy 2006; 52: 220-225. Buka okungaqondakali.
31. UNerurkar, PV, Lee, YK, Linden, EH, Lim, S., Pearson, L., Frank, J., noNerurkar, VR Lipid ukwehlisa imiphumela ye-Momordica charantia (Bitter Melon) ku-HIV-1-protease inhibitor elashwa amaseli we-hepatoma womuntu, i-HepG2. UBr J Pharmacol 2006; 148: 1156-1164. Buka okungaqondakali.
32. Shekelle, P. G., Hardy, M., Morton, S. C., Coulter, I., Venuturupalli, S., Favreau, J., noHilton, L. K. Ngabe amakhambi e-Ayurvedic esifo sikashukela ayasebenza? J Fam Khipha. 2005; 54: 876-886. Buka okungaqondakali.
33. UNerurkar, P. V., Pearson, L., Efird, J. T., Adeli, K., Theriault, A. G., noNerurkar, V. R. Microsomal triglyceride ukudlulisa amaprotheni expression kanye ne-ApoB secretion kuvinjelwe ikhabe elibabayo kumaseli weHepG2. J Okunomsoco 2005; 135: 702-706. Buka okungaqondakali.
34. USenanayake, GV, Maruyama, M., Sakono, M., Fukuda, N., Morishita, T., Yukizaki, C., Kawano, M., no-Ohta, H. Imiphumela yemonon ebabayo (Momordica charantia) imingcele ye-serum nesibindi se-lipid kuma-hamsters ondle ukudla okungenayo i-cholesterol nokudla okune-cholesterol. UJ Nutr Sci Vitaminol. (Tokyo) 2004; 50: 253-257. Buka okungaqondakali.
35. UKohno, H., Yasui, Y., Suzuki, R., Hosokawa, M., Miyashita, K., noTanaka, T. Amafutha wembewu yokudla acebile ku-conjugated linolenic acid kusuka kumakhabe ababayo kuvimbela i-rat ye-azoxymethane-induced rat colon carcinogenesis ngokusebenzisa ukuphakama ye-colonic PPARgamma expression kanye nokuguqulwa kokwakheka kwe-lipid. I-Int J Cancer 7-20-2004; 110: 896-901. Buka okungaqondakali.
36. USenanayake, GV, Maruyama, M., Shibuya, K., Sakono, M., Fukuda, N., Morishita, T., Yukizaki, C., Kawano, M., no-Ohta, H. Imiphumela yekhabe elibabayo ( Momordica charantia) kumazinga we-serum nesibindi triglyceride kumagundane. UJ Ethnopharmacol 2004; 91 (2-3): 257-262. Buka okungaqondakali.
37. UPongnikorn, S., Fongmoon, D., Kasinrerk, W., noLimtrakul, P. N. Umphumela wamakhabe ababayo (Momordica charantia Linn) ezingeni nasekusebenzeni kwamaseli okubulala emvelo ezigulini zomdlavuza wesibeletho ezine-radiotherapy. UJ Med Assoc Thai. 2003; 86: 61-68. Buka okungaqondakali.
38. URebultan, S. P. Ukwelashwa kwamakhabe: ukwelashwa kokuhlola ukutheleleka nge-HIV. I-AIDS Asia 1995; 2: 6-7. Buka okungaqondakali.
39. U-Lee-Huang, S., Huang, PL, Sun, Y., Chen, HC, Kung, HF, Huang, PL, noMurphy, WJ Inhibition we-MDA-MB-231 womuntu wesifuba isimila xenografts kanye ne-HER2 expression by anti-tumor abenzeli i-GAP31 ne-MAP30. I-Anticancer Res 2000; 20 (2A): 653-659. Buka okungaqondakali.
40. UWang, YX, Jacob, J., Wingfield, PT, Palmer, I., Stahl, SJ, Kaufman, JD, Huang, PL, Huang, PL, Lee-Huang, S., noTorchia, i-DA Elwa ne-HIV kanye ne-anti -tumor protein MAP30, a 30 kDa single-strand type-I RIP, share the similar secondary form and beta-sheet topology with A chain of ricin, a type-II RIP. Amaprotheni Sci. 2000; 9: 138-144. Buka okungaqondakali.
41. UWang, YX, Neamati, N., Jacob, J., Palmer, I., Stahl, SJ, Kaufman, JD, Huang, PL, Huang, PL, Winslow, HE, Pommier, Y., Wingfield, PT, Lee- I-Huang, S., Bax, A., ne-Torchia, i-DA Solution structure ye-anti-HIV-1 ne-anti-tumor protein MAP30: ukuqonda kwesakhiwo emisebenzini yayo eminingi. Iseli 11-12-1999; 99: 433-442. Buka okungaqondakali.
42. I-Basch E, iGabardi S, i-Ulbricht C. I-melon melon (Momordica charantia): ukubuyekezwa kokusebenza nokuphepha. NginguJ J Health Syst Pharm 2003; 60: 356-9. Buka okungaqondakali.
43. UDans AM, uVillarruz MV, uJimeno CA, et al. Umphumela wokulungiswa kwe-Momordica charantia capsule kulawulo lwe-glycemic kuhlobo lwe-2 yesifo sikashukela kudinga izifundo ezengeziwe. UJ Clin Epidemiol 2007; 60: 554-9. Buka okungaqondakali.
44. I-Shibib BA, i-Khan LA, i-Rahman R. Umsebenzi we-Hypoglycaemic we-Coccinia indica kanye ne-Momordica charantia kumagundane esifo sikashukela: ukucindezeleka kwama-enzyme e-hepatic gluconeogenic glucose-6-phosphatase kanye ne-fructose-1,6-bisphosphatase nokuphakama kwesibindi neseli elibomvu-shunt i-enzyme i-glucose-6-phosphate dehydrogenase. I-Biochem J 1993; 292: 267-70. Buka okungaqondakali.
45. U-Ahmad N, u-Hassan MR, u-Halder H, uBennoor KS. Umphumela we-Momordica charantia (Karolla) ekhishwa emazingeni wokuzila ukudla kanye ne-postprandial serum glucose kwiziguli ze-NIDDM (abstract). IBangladesh Med Res Council Bull 1999; 25: 11-3. Buka okungaqondakali.
46. U-Aslam M, uStockley IH. Ukusebenzisana phakathi kwesithako se-curry (karela) nesidakamizwa (i-chlorpropamide). ILancet 1979: 1: 607. Buka okungaqondakali.
47. U-Anila L, Vijayalakshmi NR. Imiphumela ezuzisayo yama-flavonoid avela eSesamum indicum, Emblica officinalis naseMomordica charantia. I-Phytother Res 2000; 14: 592-5. Buka okungaqondakali.
48. UGrover JK, Vats V, Rathi SS, Dawar R. Izitshalo zendabuko ezilwa nesifo sikashukela zinciphisa ukuqhubekela phambili kokulimala kwezinso ku-streptozotocin amagundane esifo sikashukela. UJ Ethnopharmacol 2001; 76: 233-8. Buka okungaqondakali.
49. UVikrant V, uGrover JK, uTandon N, et al. Ukwelashwa ngokukhishwa kweMomordica charantia ne-Eugenia jambolana kuvimbela i-hyperglycemia ne-hyperinsulinemia kumagundane aphethwe yi-fructose. UJ Ethnopharmacol 2001; 76: 139-43. Buka okungaqondakali.
50. ULee-Huang S, uHuang PL, uNara PL, et al. MAP 30: i-inhibitor entsha yokutheleleka nge-HIV-1 nokuphindaphindeka. AMA-FEBS Lett 1990; 272: 12-8. Buka okungaqondakali.
51. ULee-Huang S, uHuang PL, uHuang PL, et al. Ukuvinjelwa kokuhlanganiswa kwe-human immunodeficiency virus (HIV) yohlobo 1 ngamaphrotheni ezitshalo ezilwa negciwane lesandulela ngculaza i-MAP30 ne-GAP31. I-Proc Natl Acad Sci U S A 1995; 92: 8818-22. Buka okungaqondakali.
52. UJiratchariyakul W, iWiwat C, uVongsakul M, et al. I-HIV inhibitor ephuma emhlolweni obabayo wase-Thai. UPlanta Med 2001; 67: 350-3. Buka okungaqondakali.
53. I-Bourinbaiar AS, i-Lee-Huang S. Umsebenzi wamaprotheni we-antiretroviral atholakala ezitshalweni i-MAP30 ne-GAP31 elwa negciwane le-herpes simplex in vitro. I-Biochem Biophys Res Commun 1996; 219: 923-9. Buka okungaqondakali.
54. USchreiber CA, Wan L, uSun Y, et al. Ama-antiviral agents, i-MAP30 ne-GAP31, awanabuthi ku-spermatozoa somuntu futhi angasiza ekuvimbeleni ukudluliswa kwezocansi kohlobo lwegciwane lesandulela ngculaza lomuntu 1. Fertil Steril 1999; 72: 686-90. Buka okungaqondakali.
55. UNaseem MZ, uPatil SR, uPatil SR, et al. Imisebenzi ye-Antispermatogenic ne-androgenic yeMomordica charantia (Karela) kumagundane e-albino. UJ Ethnopharmacol 1998; 61: 9-16. Buka okungaqondakali.
56. USarkar S, Pranava M, Marita R. Ukubonakaliswa kwesenzo se-hypoglycemic sikaMomordica charantia kwimodeli yezilwane eqinisekisiwe yesifo sikashukela. I-Pharmacol Res 1996; 33: 1-4. Buka okungaqondakali.
57. UCakici I, uHurmoglu C, uTunctan B, et al. Umphumela we-Hypoglycaemic we-Momordica charantia ekhishwa kumagundane e-normoglycaemic noma e-cyproheptadine-induced hyperglycaemic. UJ Ethnopharmacol 1994; 44: 117-21. Buka okungaqondakali.
58. U-Ali L, uKhan AK, uMamun MI, et al. Ucwaningo ngemiphumela ye-hypoglycemic yezithelo zomuthi, imbewu, kanye nesitshalo sonke seMomordica charantia kumagundane ajwayelekile nawesifo sikashukela. UPlanta Med 1993; 59: 408-12. Buka okungaqondakali.
59. Usuku C, Cartwright T, Provost J, Bailey CJ. Umphumela we-Hypoglycaemic wokukhishwa kweMomordica charantia. UPlanta Med 1990; 56: 426-9. Buka okungaqondakali.
60. I-Leung SO, Yeung HW, iLeung KN. Imisebenzi yokuzivikela yokuzivikela kwamaprotheni amabili akhipha isisu ahlukaniswe nembewu yekhabe elibabayo (Momordica charantia). I-Immunopharmacol 1987; 13: 159-71. Buka okungaqondakali.
61. UJilka C, uStrifler B, uFortner GW, et al. Emsebenzini we-vivo antitumor wekhabe elibabayo (Momordica charantia). ICancer Res 1983; 43: 5151-5. Buka okungaqondakali.
62. UCunnick JE, uSakamoto K, Chapes SK, et al. Ukungeniswa kwamangqamuzana omzimba we-tumor cytotoxic asebenzisa iphrotheni kusuka kumakhabe ababayo (Momordica charantia). Iseli Immunol 1990; 126: 278-89. Buka okungaqondakali.
63. U-Lee-Huang S, Huang PL, Chen HC, et al. Imisebenzi elwa ne-HIV kanye ne-anti-tumor ye-MAP30 ephindaphindayo evela kumakhabe amuncu. UGene 1995; 161: 151-6. Buka okungaqondakali.
64. I-Bourinbaiar AS, u-Lee-Huang S. Ukutholakala komsebenzi olwa ne-HIV wemithi elwa nokuvuvukala, i-dexamethasone ne-indomethacin, yi-MAP30, i-ejenti elwa namagciwane aphuma kumakhabe ababayo. I-Biochem Biophys Res Commun 1995; 208: 779-85. Buka okungaqondakali.
65. IBaldwa VS, iBhandari CM, iPangaria A, iGoyal RK. Isivivinyo somtholampilo ezigulini ezinesifo sikashukela se-insulin efana ne-insulin etholakala emithonjeni yezitshalo. Ama-Ups J Med Sci 1977; 82: 39-41. Buka okungaqondakali.
66. URaman A, et al. Izakhiwo ezilwa nesifo sikashukela kanye ne-phytochemistry kaMomordica charantia L. (Cucurbitaceae). I-Phytomedicine 1996; 294.
67. USrivastava Y, Venkatakrishna-Bhatt H, Verma Y, et al. Izici ze-Antidiabetic kanye ne-adaptogenic ye-Momordica charantia ekhishwe: Ukuhlolwa kokuhlola nokwelashwa. I-Phytother Res 1993; 7: 285-9.
68. UWelihinda J, et al. Umphumela we-Momordica charantia ekubekezeleni kwe-glucose ekuvuthweni kokuqala kwesifo sikashukela. UJ Ethnopharmacol 1986; 17: 277-82. Buka okungaqondakali.
69. ULeatherdale B, uPanesar RK, uSingh G, et al. Ukwenza ngcono ukubekezelelana kwe-glucose ngenxa ye-Momordica charantia. UBr Med J (Clin Res Ed) 1981; 282: 1823-4. Buka okungaqondakali.
70. UBlumenthal M, u-ed. I-Complete German Commission E Monographs: Umhlahlandlela Wezokwelapha Emithini Yemithi. I-Trans. S. Klein. IBoston, MA: Umkhandlu Wezamabhodlela waseMelika, ngo-1998.
71. Ama-monographs ngokusetshenziswa kokwelashwa kwemithi yezitshalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.

Kugcine ukubuyekezwa - 11/25/2020